Functional capacity in idiopathic pulmonary fibrosis: Looking beyond the lungs

Respirology

Volumn 20, Issue 6, 2015, Pages 857-858

  Holland, Anne E ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

activity of daily living; atrophy; exercise; pulmonary fibrosis; skeletal muscle

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DAILY LIFE ACTIVITY; DISABILITY; DISEASE COURSE; DYSPNEA; EDITORIAL; EXERCISE TOLERANCE; EXHAUSTION; FATIGUE; FIBROSING ALVEOLITIS; FUNCTIONAL STATUS; HUMAN; KINESIOTHERAPY; LIMB DISEASE; MUSCLE DISEASE; MUSCLE WEAKNESS; PHYSICAL ACTIVITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REHABILITATION CARE; TREATMENT DURATION; WELLBEING; FEMALE; INTERSTITIAL LUNG DISEASE; MALE; MUSCLE STRENGTH; PATHOLOGY; SKELETAL MUSCLE;

FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL;

EID: 84937024402     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12581     Document Type: Editorial

References (11)

1. Wallaert B, Monge E, Le Rouzic O, Wemeau-Stervinou L, Salleron J, Grosbois JM,. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013; 144: 1652-1658.
2. Wickerson L, Mathur S, Helm D, Singer L, Brooks D,. Physical activity profile of lung transplant candidates with interstitial lung disease. J Cardiopulm Rehabil Prev. 2013; 33: 106-112.
3. King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2083-2092.
4. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2071-2082.
5. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M, Hernandez P, Rouleau M, Julien M, Parenteau S, et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2008; 149: 869-878.
6. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Arizono S,. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005; 127: 2028-2033.
7. Mendoza L, Gogali A, Shrikrishna D, Cavada G, Kemp SV, Natanek SA, Jackson AS, Polkey MI, Wells AU, Hopkinson NS,. Quadriceps strength and endurance in fibrotic idiopathic interstitial pneumonia. Respirology 2014; 19: 138-143.
8. Mendes P, Wickerson L, Helm D, Janaudis-Ferreira T, Brooks D, Singer LG, Mathur S,. Skeletal muscle atrophy in advanced interstitial lung disease. Respirology 2015; doi: 10.1111/resp.12571.
9. Vainshelboim B, Oliveira J, Yehoshua L, Weiss I, Fox BD, Fruchter O, Kramer MR,. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration 2014; 88: 378-388.
10. Dowman L, Hill CJ, Holland AE,. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst. Rev. 2014; 10: CD006322.
11. The diagnosis and management of suspected idiopathic pulmonary fibrosis: NICE clinical guideline 163. National Institute for Health and Care Excellence, United Kingdom. 2013.